Clinical Trial Update: Combining ICI With SBRT or HypoFrx-RT for ES NSCLC [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating combining immune checkpoint inhibitors with SBRT or hypo-fractionated radiotherapy for non-small cell lung cancer across mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Alexander Chi | Conditions: Non-small Cell Lung Cancer, Non-small Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN